MOA

Share / Send / Save

Only FIRAZYR directly blocks the activity of bradykinin

FIRAZYR is used to treat acute HAE attacks in adults 18 years of age and older. It blocks bradykinin from binding the BK2 receptor, thereby treating the clinical symptoms of an acute HAE attack.1,2